介质细胞干细胞衍生的细胞外囊:寻求无细胞疗法治疗受骨影响的溶酶体储存障碍
Andrés Felipe Leal1,2,3,4, Harry Pachajoa1,2,5, Shunji Tomatsu4,6,7
1Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras, Universidad Icesi, Cali 760031, Colombia.
International journal of molecular sciences
|July 12, 2025
概括
介质细胞干细胞衍生的细胞外囊泡 (MSC-EVs) 为骨受影响的溶酶体储存障碍 (LSDs) 提供了一种新的无细胞疗法. 这些工程EV可以准骨,提供治疗方法来解决LSD的骨异常和微环境干扰.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 溶酶体储存障碍 (LSD) 导致基质积累和溶酶体功能障碍,往往导致严重的骨表现.
- 目前的疗法,如酶替代疗法 (ERT) 和基因疗法 (GT),在纠正LSD的骨异常方面有效性有限.
- 微环境干扰在很大程度上导致LSD的发病,需要新的治疗方法.
研究的目的:
- 探索介质干细胞衍生的细胞外囊泡 (MSC-EVs) 的治疗潜力,用于骨受影响的LSDs.
- 突出MSC-EVs调节骨微环境和提供治疗药物的能力.
- 审查MSC-EVs作为解决LSD骨并发症的无细胞策略.
主要方法:
- 对LSDs,骨表现和MSC-EVs的当前文献的审查.
- 分析MSC-EV的特性,包括免疫调节和再生效应.
- 讨论MSC-EV工程,以有针对性地将与ERT和GT相关的分子输送到骨.
主要成果:
- MSC-EVs具有适用于骨疾病中的组织修复的固有特性.
- 工程MSC-EV可以被导向骨组织以提供向的治疗.
- MSC-EV在调节微环境和潜在地纠正LSD骨异常方面表现有前途.
结论:
- MSC-EVs代表了一种有希望的无细胞治疗策略,用于骨受影响的LSDs.
- 针对溶解体功能障碍和微环境调节障碍对于有效的LSD治疗至关重要.
- 对MSC-EV的进一步研究可能会导致对LSD骨表现的改善治疗方法.
相关概念视频
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K


